These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M, Mitsuhashi S. Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313 [Abstract] [Full Text] [Related]
10. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C, Ishii C, Sakagawa E, Harasaki T, Hirasawa A, Abe T, Yasuda H, Iwata M, Kuwahara S. Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035 [Abstract] [Full Text] [Related]
14. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom. King A, Boothman C, Phillips I. J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214 [Abstract] [Full Text] [Related]